Who we are

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve outcomes and enhance lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow.

Charities of the Year

Meet the good causes we support that improve human and animal health

UKRAINE

£25k donated to Ukrainian families and animals

Reporting suspected side effects and other adverse events for Boehringer Ingelheim medicinal products in Ireland

Terms and Conditions relating to the Sale of Goods

Our New Offices in Ireland

Creating a sense of togetherness